Chiropractors in Manning, SC Accepting Medicare
3 Chiropractors found. Showing 1 - 3
 Dr. Brent D Carraway, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 601 B South Mill Street, Manning, SC 29102 Phone: 803-435-4050 Fax: 803-435-8096 |
 Scott Brown Dc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 207 Boundary St, Manning, SC 29102 Phone: 803-433-2992 Fax: 803-433-0084 |
Dr. Scott D Brown, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 207 Boundary St, Manning, SC 29102 Phone: 803-433-2992 Fax: 803-433-0084 |
News Archive
Shedding new LIGHT on disease
New drugs for the 270,000 people who suffer heart attacks every year in the UK will be among the projects in Leeds' new research institute. The Leeds Institute of Genetics Health and Therapeutics (LIGHT) was opened by head of the Medical Research Council chief executive Professor Colin Blakemore yesterday.
Miniature brains that can move muscles, grown in the lab
Researchers have successfully created miniature organoid brains in the labs that when attached to a spinal cord and muscles could help move the muscles.
Johns Hopkins researchers find no evidence of CMV in aggressive brain cancer tissues
In a rigorous study of tumor tissue collected from 125 patients with aggressive brain cancers, researchers at Johns Hopkins say they have found no evidence of cytomegalovirus (CMV) infection and conclude that a link between the two diseases, as claimed by earlier reports, likely does not exist.
New research: Rectal specific microbicides can protect against HIV
Microbicides can be used to protect against HIV, and other sexually transmitted diseases, either on their own or with the added protection of a condom. New research published by BioMed Central's open access journal AIDS Research and Therapy has investigated the use of lubricants, originally designed for vaginal application, and has developed and tested new, rectal specific, formulations.
Genentech receives FDA approval for Perjeta to treat HER2-positive metastatic breast cancer
The U.S. Food and Drug Administration today approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage (metastatic) breast cancer.
› Verified 4 days ago
Optometrists
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors